Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
European Urology|September 18, 2012
Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinomaAlexander B Stillebroer, Otto C Boerman, Ingrid M E Desar, et al.European Urology|December 27, 2015
Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell CarcinomaConstantijn H J Muselaers, Marye J Boers-Sonderen, Tim J van Oostenbrugge, et al.European Urology|July 8, 2008
Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsyAlexander Haese, Alexandre de la Taille, Hendrik van Poppel, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2014
Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinomaConstantijn H J Muselaers, Alexander B Stillebroer, Ingrid M E Desar, et al.BJU International|March 17, 2010
The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?Guillaume Ploussard, Alexander Haese, Hendrik Van Poppel, et al.European Urology|March 24, 2009
Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogramFelix K Chun, Alexandre de la Taille, Hendrik van Poppel, et al.Pageof 2